Maria E. Santaella, M.S.N., RN-BC, hemophilia nurse coordinator in the Department of Pediatrics at the University of Miami Miller School of Medicine, has received the Nurse of the Year Award from the National Hemophilia Foundation (NHF). The award was presented during the foundation’s recent annual meeting in Chicago.
Stephen D. Nimer, M.D., director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, was awarded a $300,000 Translational Research Program grant from the Leukemia and Lymphoma Society (LLS). Nimer’s laboratory has been studying the RUNX1 protein, previously referred to as AML1, because it is commonly involved in chromosomal translocations seen in acute myeloid leukemia (AML).
Even before Hurricane Irma’s winds had finally subsided, the Miller School of Medicine campus was in recovery mode, making sure that it, and the University of Miami Health System satellite facilities, would be able to return to business as usual with minimal delay. In fact, with few exceptions, operations were back to normal on Wednesday morning, as employees returned to work, and patients began arriving for appointments.
A predictive tumor biomarker can help clinicians identify lung cancer patients who are most likely to benefit from immunotherapy, according to Gilberto de Lima Lopes, Jr., M.D., M.B.A., a researcher at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.
An enthusiastic group of University of Miami Miller School of Medicine students, residents, faculty members and administrators attended the annual meeting of the Florida Medical Association last month, and one student was honored for his research work at Sylvester Comprehensive Cancer Center.
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has been reaccredited by the Quality Oncology Practice Initiative (QOPI) Certification Program of the American Society of Clinical Oncology (ASCO). This program awards a three-year certification for outpatient hematology-oncology practices that meet nationally recognized standards for quality cancer care.
Research efforts to improve outcomes for people with ovarian cancer or glioma just got a boost in excess of $3 million. Noriyuki Kasahara, M.D., Ph.D., a researcher at Sylvester Comprehensive Cancer Center and professor of biology and pathology at the University of Miami Miller School of Medicine, and colleagues have received a $2.6 million NCI grant to support their unique technology to deliver targeted chemotherapy.
For Peruvian native Julio Barredo, M.D., director of children’s cancer programs at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, visits to his home country were often painful. He saw a cure rate of only 40 percent for the 700 children diagnosed annually with acute lymphoblastic leukemia, the most common childhood cancer. He knew that many of them were dying unnecessarily.
It was just a staircase, but to Patricia Emard, it could have been a mountain. With the help of the world-class oncologists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, she had triumphed over breast cancer, but it had taken all she could give. Two surgeries, chemotherapy and radiation had sapped her strength. She looked at the staircase and chose the elevator instead.
The Personalized Medicine Coalition (PMC), a prestigious group representing innovators, scientists, patients, providers and payers, has invited Sylvester Comprehensive Cancer Center to join its membership. “The invitation signifies their recognition of our strong work in this area,” said Jonathan C. Trent, M.D., Ph.D., Sylvester’s director of precision medicine.